Telomerase: Putting an End to DNA

References

• Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996; 8: 66–71
   PubMedGoogle Scholar
• Shay JW. Aging and cancer: Are telomeres and telomerase the connection?. Mol Med Today 1995; 1: 378–384
   PubMedGoogle Scholar
• Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–2015
   PubMed Web of Science ®Google Scholar
• Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomeruse activity levels with human neuroblastoma outcomes. Nature Med 1995; 1: 249–255
   PubMed Web of Science ®Google Scholar
• Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458–460
   PubMed Web of Science ®Google Scholar
• Harley CB. Telomere loss: Mitotic clock or genetic time bomb. Mutat Res 1991; 256: 271–281
   PubMed Web of Science ®Google Scholar
• Muller HJ. The remaking of chromosomes. The collecting net. WoodsHole 1938; 13: 181–198
   Google Scholar
• McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941; 41: 234–282
   Google Scholar
• Allshire RC, Gosden JR, Cross SH, et al. Telomeric repeat from T. thermopila cross hybridizes with human telomeres. Nature 1988; 332: 656–659
   PubMed Web of Science ®Google Scholar
• Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence, (TTAGGGn), present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622–6626
   PubMed Web of Science ®Google Scholar
• Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521–529
   PubMed Web of Science ®Google Scholar
• deLange T. Human telomeres are attached to the nuclear matrix. EMBO J 1992; 11: 717–724
   PubMed Web of Science ®Google Scholar
• Brown W RA, MacKinnon PJ, Villasante A, et al. Structure and polymorphism of human telomere-associated DNA. Cell 1990; 63: 119–132
   PubMed Web of Science ®Google Scholar
• Chong L, van Steensel B, Broccoli D, et al. A human telomeric protein. Science 1995; 270: 1663–1667
   PubMed Web of Science ®Google Scholar
• Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405–413
   PubMed Web of Science ®Google Scholar
• Greider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987; 51: 887–898
   PubMed Web of Science ®Google Scholar
• Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989; 337: 331–337
   PubMed Web of Science ®Google Scholar
• Piatyszek MA, Kim NW, Weinrich SL, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995; 17: 1–15
   Google Scholar
• Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucl Acids Res 1995; 23: 3794–3795
   PubMed Web of Science ®Google Scholar
• Oncor TRAPeze Telomerase Detection Kit. Gaithersburg, MD August, 1996, Edition 2
   Google Scholar
• Holt SE, Norton JC, Wright WE, et al. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Meth Cell Sci 1996; 16: 1–12
   Google Scholar
• Yu GL, Bradley JD, Attardi LD, et al. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 1990; 344: 126–132
   PubMed Web of Science ®Google Scholar
• Gilley D, Lee MS, Blackburn EH. Altering specific telomerase RNA template residues affects active site function. Genes Dev 1995; 9: 2214–2226
   PubMed Web of Science ®Google Scholar
• Avilion AA, Piatyszek MA, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56: 645–650
   PubMed Web of Science ®Google Scholar
• Harrington L, McPhail T, Mar V, et al. A mammalian telomerase-associated protein. Science 1997; 275: 973–977
   PubMed Web of Science ®Google Scholar
• Kirk KE, Harmon BP, Reichardt IK, et al. Block in anaphase chromosome separation caused by a telomerase template mutation. Science 1997; 275: 1478–1481
   PubMed Web of Science ®Google Scholar
• Bryan TM, Englezou A, Gupta J, et al. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14: 4240–4248
   PubMed Web of Science ®Google Scholar
• Wright WE, Brasiskyte D, Piatyszek MA, et al. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J 1996; 15: 1734–1741
   PubMed Web of Science ®Google Scholar
• Ohmura H, Tahara H, Suzuki M, et al. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995; 86: 899–904
   PubMedGoogle Scholar
• Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380: 79–82
   PubMed Web of Science ®Google Scholar
• Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711–3715
   PubMed Web of Science ®Google Scholar
• Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun 1996; 219: 649–655
   PubMed Web of Science ®Google Scholar
• Weng NP, Levine BL, June CH, et al. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183: 2471–2479
   PubMed Web of Science ®Google Scholar
• Blasco MA, Funk W, Villeponteau B, et al. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995; 269: 1267–1270
   PubMed Web of Science ®Google Scholar
• Sharma HW, Sokoloski JA, Perez JR, et al. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 1995; 92: 12343–12346
   PubMed Web of Science ®Google Scholar
• Albanell J, Han W, Mellado B, et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res 1996; 56: 1503–1508
   PubMed Web of Science ®Google Scholar
• Savoysky E, Yoshida K, Ohtomo T, et al. Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochem Biophys Res Commun 1996; 226: 329–334
   PubMed Web of Science ®Google Scholar
• Bestilny LJ, Brown CB, Miura Y, et al. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 1996; 56: 3796–3802
   PubMed Web of Science ®Google Scholar
• Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93: 6476–6481
   PubMed Web of Science ®Google Scholar
• Blasco MA, Rizen M, Greider CW, et al. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genet 1996; 12: 200–204
   PubMed Web of Science ®Google Scholar
• Kipling D. Telomerase: Immortality enzyme or oncogene. Nature Genet 1995; 9: 104–106
   PubMed Web of Science ®Google Scholar
• Morin GB. Is telomerase a universal cancer target. J Natl Cancer Inst 1995; 87: 859–861
   PubMed Web of Science ®Google Scholar
• Parkinson EK. Do telomerase antagonists represent a novel anticancer strategy. Br J Cancer 1996; 73: 1–4
   PubMed Web of Science ®Google Scholar
• Wang S-S, Zakian VA. Telomere-telomere recombination provides an express pathway for telomere acquisition. Nature 1990; 345: 456–458
   PubMed Web of Science ®Google Scholar
• Gupta J, Han LP, Wang P, et al. Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst 1996; 88: 1152–1157
   PubMed Web of Science ®Google Scholar
• Morin GB. Telomere integrity and cancer. J Natl Cancer Inst 1996; 88: 1095–1096
   PubMed Web of Science ®Google Scholar
• Shay JW, Werbin H, Wright WE. Telomeres and telomerase in human leukemias. Leukemia 1996; 10: 1255–1261
   PubMed Web of Science ®Google Scholar
• Swift M, Morrell D, Massey RB, et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831–1836
   PubMed Web of Science ®Google Scholar
• Bilaud T, Koering CE, Binet-Brasselet E, et al. The telobox, a Myb-related telomeric DNA binding motif found in proteins from yeast, plants, and human. Nucl Acids Res 1996; 24: 1294–1303
   PubMed Web of Science ®Google Scholar
• Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955–959
   PubMed Web of Science ®Google Scholar
• Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785–795
   PubMed Web of Science ®Google Scholar
• Blasco MA, Lee H-W, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91: 25–34
   PubMed Web of Science ®Google Scholar